Crossmark Global Holdings Inc. Sells 199 Shares of Piper Sandler Companies (NYSE:PIPR)

Crossmark Global Holdings Inc. cut its position in Piper Sandler Companies (NYSE:PIPR) by 12.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,349 shares of the financial services provider’s stock after selling 199 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Piper Sandler Companies were worth $405,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV grew its position in shares of Piper Sandler Companies by 5.4% in the second quarter. Mercer Global Advisors Inc. ADV now owns 1,317 shares of the financial services provider’s stock valued at $303,000 after purchasing an additional 67 shares during the last quarter. Hsbc Holdings PLC boosted its stake in Piper Sandler Companies by 12.2% during the 2nd quarter. Hsbc Holdings PLC now owns 3,338 shares of the financial services provider’s stock valued at $760,000 after purchasing an additional 363 shares during the period. Sei Investments Co. grew its holdings in Piper Sandler Companies by 101.2% in the 2nd quarter. Sei Investments Co. now owns 44,675 shares of the financial services provider’s stock valued at $10,282,000 after buying an additional 22,471 shares during the last quarter. Bank of Montreal Can increased its position in Piper Sandler Companies by 2.1% in the 2nd quarter. Bank of Montreal Can now owns 2,262 shares of the financial services provider’s stock worth $524,000 after buying an additional 46 shares during the period. Finally, Xponance Inc. lifted its holdings in shares of Piper Sandler Companies by 4.6% during the second quarter. Xponance Inc. now owns 1,101 shares of the financial services provider’s stock worth $253,000 after buying an additional 48 shares during the last quarter. Institutional investors own 72.79% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. The Goldman Sachs Group downgraded shares of Piper Sandler Companies from a “buy” rating to a “neutral” rating and set a $317.00 price objective on the stock. in a research note on Monday, January 6th. StockNews.com downgraded shares of Piper Sandler Companies from a “buy” rating to a “hold” rating in a report on Tuesday, January 7th.

Piper Sandler Companies Stock Performance

Piper Sandler Companies stock opened at $306.40 on Monday. Piper Sandler Companies has a 12 month low of $171.70 and a 12 month high of $351.80. The firm has a market cap of $5.45 billion, a PE ratio of 32.73 and a beta of 1.46. The firm has a 50 day moving average price of $299.86.

Piper Sandler Companies (NYSE:PIPR) last issued its earnings results on Friday, October 25th. The financial services provider reported $2.57 EPS for the quarter, topping the consensus estimate of $2.53 by $0.04. Piper Sandler Companies had a return on equity of 16.06% and a net margin of 10.84%. The firm had revenue of $359.57 million during the quarter, compared to analysts’ expectations of $365.07 million. As a group, sell-side analysts expect that Piper Sandler Companies will post 11.49 earnings per share for the current year.

Piper Sandler Companies Company Profile

Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. It offers investment banking services and institutional sales, trading, and research services for various equity and fixed income products; advisory services, such as mergers and acquisitions, equity and debt private placements, and debt and restructuring advisory; raises capital through equity and debt financings; underwrites municipal issuances; and municipal financial advisory and loan placement services, as well as various over-the-counter derivative products.